s6y

3 Acer Therapeutics Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0001654954-17-008669

Documents

  1. PRIMARY DOCUMENT 3
  2. POWER OF ATTORNEY EX-24

On sec.gov